Eli Lilly And Company (LLY) fundamentals score
Eli Lilly and Company (referred to as the company, Lilly, we, or it) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. It discovers, develops, manufactures, ands market products in a single business segment—human pharmaceutical products.
Pharmaceutical Preparations · Healthcare · Listed on NYSE
Overall: 7.6 out of 10, Mixed fundamentals
- Growth: 7.7/10
- Profitability: 8.9/10
- Financial health: 6.0/10
- Earnings quality: 7.5/10
- Valuation: 7.7/10
Scores are calculated from Eli Lilly And Company’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10